Michele Korfin
Direttore/Membro del Consiglio presso ORGANOGENESIS HOLDINGS INC.
Patrimonio netto: 334 146 $ in data 30/04/2024
Posizioni attive di Michele Korfin
Società | Posizione | Inizio | Fine |
---|---|---|---|
ORGANOGENESIS HOLDINGS INC. | Direttore/Membro del Consiglio | 03/05/2022 | - |
Independent Dir/Board Member | 03/05/2022 | - | |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Direttore/Membro del Consiglio | - | - |
Segretario Aziendale | 13/02/2020 | - |
Storia della carriera di Michele Korfin
Precedenti posizioni note di Michele Korfin
Società | Posizione | Inizio | Fine |
---|---|---|---|
GAMIDA CELL LTD. | Direttore operativo | 01/08/2020 | 01/04/2024 |
TYME TECHNOLOGIES, INC. | Direttore operativo | 15/03/2019 | 01/01/2020 |
Corporate Officer/Principal | 15/10/2018 | 15/03/2019 | |
KITE PHARMA INC | Corporate Officer/Principal | 01/01/2016 | 01/07/2018 |
CELGENE | Corporate Officer/Principal | 01/01/2004 | 01/03/2016 |
Formazione di Michele Korfin
Harvard Business School | Masters Business Admin |
Rutgers State University of New Jersey | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Francia | 2 |
Israele | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Operating Officer | 2 |
Director/Board Member | 2 |
Settori
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
GAMIDA CELL LTD. | Health Technology |
ORGANOGENESIS HOLDINGS INC. | Health Technology |
Aziende private | 4 |
---|---|
Tyme Technologies, Inc.
Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Kite Pharma, Inc.
Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Borsa valori
- Insiders
- Michele Korfin
- Esperienza